Interventional Cardiology Market in North America - Annualized Market Revenues (USD), Volume (units) and Average Prices (USD) Data from 2015 to 2025
31 déc. 2020 03h53 HE
|
Research and Markets
Dublin, Dec. 31, 2020 (GLOBE NEWSWIRE) -- The "North America Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been...
United Kingdom Interventional Cardiology Market Databook with Annualized Market Revenues (USD), Volume (units) and Average Prices (USD) Data for Each of the Market Segments
23 déc. 2020 02h43 HE
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "United Kingdom Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been...
Global Percutaneous Coronary Intervention Market Analysis - 2018-2027
09 nov. 2020 07h58 HE
|
Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Global Percutaneous Coronary Intervention Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering. The global percutaneous...
Global Coronary Stent Market to Witness a CAGR of 8.7% during 2019-2025
08 mai 2019 07h53 HE
|
Energias Market Research
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- The global coronary stent market is expected to grow from USD 7,756 million in 2018 to USD 13,907 million in 2025, at a CAGR of 8.7% from 2019 to 2025. The...
Amaranth Presented Interim Nine-Month Follow-up MAGNITUDE (98 micron) and Two-Year Follow-up APTITUDE (115 micron) Data at EuroPCR Symposium
23 mai 2018 08h30 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 23, 2018 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, provided...
Amaranth Medical Showcases Breadth of BRS Pipeline at TCT, Unveiling 9-mo Interim Imaging Results from 98 micron MAGNITUDE and Update on 115-micron APTITUDE
25 oct. 2017 13h21 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, will...
Amaranth Medical Initiates Trial of Sub-100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
01 nov. 2016 08h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of a clinical study of the Company’s latest-generation...
Global and China Coronary Stent Market to Benefit from Rising Demand for Minimally Invasive Treatments: QYResearchReports.com
14 juil. 2016 08h33 HE
|
QY Research Reports
Brooklyn, NY , July 14, 2016 (GLOBE NEWSWIRE) -- The aging population is increasingly accepting minimally invasive surgeries and treatments. Advances in medical devices and the rising government...
Amaranth Medical On Track to Complete Enrollment in RENASCENT-II Study of 120-Micron APTITUDE™ Sirolimus-Eluting Bioresorbable Scaffold in May
18 mai 2016 03h01 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 18, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, provided a clinical update on its ongoing RENASCENT-II study of its novel APTITUDE™...